Why I Will NOT be Implanting the CyPass® into my Younger Patients with Glaucoma
Image Source: Medgadget via https://youtu.be/8oAjFQwqgnM 08.29.2018 NEWS UPDATE: Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma | SOURCE:...FDA-Approved Incisional Treatments for Glaucoma – IStent®, Cypass® Microstent, Xen® 45 Gel Stent, Cataract Surgery
Part 11 of 14 of “Adjusting the Faucet or Opening the Drain – Currently Available Methods to Treat the Plumbing Problem of Open Angle Glaucoma” | A San Gabriel Valley Optometric Society (SGVOS) Continuing Education Dinner Event – 2 hours CE | Featured...CyPass Glaucoma Micro-Stent® – Two-Year Results
Two new Micro-Invasive Glaucoma Surgery (MIGS) implants gained FDA approval in 2016: the Alcon CyPass Micro-Stent® and the Allergan XEN® Gel Implant. Of these, only the CyPass Micro-Stent® offers a bleb-free method of reducing intraocular pressure (IOP). The CyPass...Suprachoroidal Implants (SOLX®, STARflo™, iStent Supra®, CyPass®)
Suprachoroidal Implants [SOLX®, STARflo™, iStent Supra®, CyPass®]. Part 10 of 12 of “What’s New In Glaucoma Surgery” Presentation, a continuing education course for Optometrists presented by Patient-Focused Ophthalmologist, Dr. David Richardson...CyPass MicroStent® Glaucoma Device Awaits FDA Approval
How Well Does the CyPass Micro-Stent® Glaucoma Device Appear to Work? What Are The Risks of CyPass Micro-Stent® surgery? Read more…
Hydrus and iStent Trabecular MicroBypass Devices | Compare Trial 24 months Results
Compare trial results at 24 months of two different minimally invasive glaucoma surgeries— the Hydrus™ and the iStent® without cataract surgery being performed at the same time.
Medical Therapy for Glaucoma: Alpha-Agonists
A Patient’s Guide to Glaucoma Medications Alpha-Agonists Medication for Glaucoma About this class and how it works: Alpha-agonists have their effect on the ciliary body to reduce production of aqueous fluid. Additionally, like the prostaglandin analogs,...Ab Interno Canaloplasty (ABiC™) In The Spotlight
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.
How Does Canaloplasty Compare to Other Glaucoma Treatments?
How does Canaloplasty compare to other glaucoma treatments in terms of IOP Lowering benefits and average medication? Here’s a summary from Dr. Douglas J. Rhee’s talk given on April 13, 2018 during the ASCRS 2018 Glaucoma Day “Is Trabeculectomy...
